AlterG

Executive Summary

AlterG is a leading medical device company specializing in anti-gravity treadmill technology that combines precise unweighting with real-time gait analytics and video feedback. Founded in 2005 and based in Fremont, California, the company's flagship product, the AlterG Anti-Gravity Treadmill, is widely used in rehabilitation, sports medicine, and fitness settings to enable low-impact training and therapy. By offloading a precise percentage of body weight, it allows patients to recover from injuries and surgeries faster while maintaining natural gait patterns. The technology is supported by a growing body of clinical evidence and is adopted by top hospitals, professional sports teams, and research institutions globally. AlterG operates in the competitive physical therapy and rehabilitation equipment market, with a strong brand and patented technology providing a moat. The company is privately held and has not disclosed recent funding or valuation, but its products are commercially established with recurring revenue from sales and service. Future growth is likely driven by expanding into new therapeutic areas (e.g., neurological rehab, geriatric fitness), international market penetration, and iterative product enhancements incorporating AI and cloud analytics. While facing competition from traditional unweighting systems and emerging exoskeleton technologies, AlterG's precision and ease of use position it well for sustained adoption.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) clearance for next-generation treadmill with AI-driven gait analytics70% success
• Q4 2026Expansion into European market through CE marking and distribution partnerships60% success
• Q2 2026Strategic partnership with a major academic medical center for a multi-site clinical trial in stroke rehabilitation80% success